Korro Bio, Inc. KRRO
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2019-10-03
Korro Bio, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 406,381 | $13.8M | 4.32% |
| AQR CAPITAL MANAGEMENT LLC | 298,974 | $3.9M | 3.17% |
| TWO SIGMA INVESTMENTS, LP | 178,071 | $2.3M | 1.89% |
| CITADEL ADVISORS LLC | 123,790 | $1.6M | 1.31% |
| MILLENNIUM MANAGEMENT LLC | 118,434 | $1.6M | 1.26% |
| RENAISSANCE TECHNOLOGIES LLC | 110,524 | $1.5M | 1.17% |
| D. E. Shaw & Co., Inc. | 34,213 | $450,927 | 0.36% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.